Join/Renew     Contact ONS     Terms of Use    FAQ 
HOME
CNE Central Clinical Practice
Membership
Patient Education
Publications
PEP/Research
Treatment
Biologics and Molecular Targeted Therapies Home
Bibliography
Education
Let's Talk About It
In the News
Additional Resources

Untitled Document
ONS Profile

 

Biologics and Molecular Targeted Therapies/Immunotherapy/Nano Technology Clinical Resource Area - In the News

FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer

Avado Study of Avastin Plus Docetaxel Chemotherapy Showed Improved Progression-Free Survival in Patients With Advanced Breast Cancer

Medscape News
This is a continuing education (CME) article entitled “Experts Welcome Accelerated Approval of Bevacizumab for Breast Cancer”.  Upon completion of post-test, .25 CME will be awarded.